Advik Laboratories Ltd.
BSE: 531686 | Sector: Health care |
NSE: N.A. | ISIN Code: INE537C01019 |
BSE 00:00 | 19 Apr | 1.01 |
0 (0.00%) |
OPEN
1.01 |
HIGH
1.01 |
LOW
1.01 |
NSE 05:30 | 01 Jan | Advik Laboratories Ltd |
OPEN | 1.01 |
PREVIOUS CLOSE | 1.01 |
VOLUME | 1200 |
52-Week high | 1.01 |
52-Week low | 0.37 |
P/E | |
Mkt Cap.(Rs cr) | 2 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Advik Laboratories Ltd. (ADVIKLABS) - Competition
COMPANY | Last Price | Market Cap. (Rs. cr.) |
Sales Turnover | Net Profit | Total Assets |
Sun Pharma.Inds. | 644.60 | 154,658.87 | 12,531.93 | 3,211.14 | 32,355.78 |
Divi's Lab. | 3,816.75 | 101,315.63 | 5,310.57 | 1,372.71 | 7,370.84 |
Dr Reddy's Labs | 5,145.90 | 85,576.32 | 11,850.40 | 2,937.70 | 16,732.90 |
Cipla | 952.70 | 76,830.49 | 12,659.15 | 2,318.17 | 17,704.77 |
Aurobindo Pharma | 989.95 | 58,001.17 | 13,266.48 | 1,872.74 | 16,809.46 |
Cadila Health. | 535.45 | 54,814.02 | 6,347.40 | 1,412.90 | 15,089.80 |
Lupin | 1,078.10 | 48,913.40 | 11,025.66 | 727.55 | 17,937.29 |
Biocon | 405.00 | 48,600.00 | 1,988.40 | 440.90 | 7,583.50 |
Apollo Hospitals | 3,287.00 | 47,260.49 | 9,794.50 | 470.30 | 8,570.00 |
Gland Pharma | 2,801.00 | 45,824.36 | 2,633.24 | 772.86 | 3,653.86 |
Torrent Pharma. | 2,617.50 | 44,293.34 | 6,168.44 | 938.51 | 10,683.66 |
Piramal Enterp. | 1,747.00 | 39,403.59 | 4,219.19 | 144.85 | 33,415.39 |
Alkem Lab | 2,746.90 | 32,839.19 | 6,677.08 | 1,264.42 | 7,728.19 |
Abbott India | 14,890.00 | 31,641.25 | 4,093.14 | 592.93 | 2,691.43 |
Ipca Labs. | 2,168.00 | 27,501.08 | 4,367.43 | 652.46 | 4,185.23 |
Pfizer | 5,432.00 | 24,851.40 | 2,151.65 | 509.13 | 3,534.54 |
Dr Lal Pathlabs | 2,944.15 | 24,536.55 | 1,273.60 | 223.18 | 1,106.64 |
Glaxosmi. Pharma | 1,439.30 | 24,383.18 | 3,224.68 | 110.05 | 2,129.60 |
Syngene Intl. | 602.80 | 24,112.00 | 2,011.90 | 411.50 | 3,313.70 |
Laurus Labs | 442.90 | 23,766.01 | 2,797.34 | 267.05 | 2,966.39 |
Quick Links for Advik Laboratories:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices